Jennifer Chwalek, MD
Dermatology · Union City, CANPI 1407999667
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Solta Medical, A Division Of Bausch Health US, LLC at 53.8% of the total. Reporting peaked in 2023 at $7,693 and has fallen 93.9% since, to $472 in 2025.
Across 79 payments — averaging $177.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Solta Medical, A Division Of Bausch Health US, LLC$8K
- Sun Pharmaceutical Industries Inc.$5K
- AbbVie$770
- LEO Pharma Inc.$101
- Arcutis Biotherapeutics, Inc.$94
- Mayne Pharma Commercial LLC$90
- plus $477 from 15 others
What the payments were for
- Consulting fees$7,50054%
- Speaking & faculty fees$4,90235%
- Food & beverage$1,58311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $7,520 |
| Sun Pharmaceutical Industries Inc. | 3 | $4,932 |
| AbbVie(2 entities) | 38 | $770 |
| LEO Pharma Inc. | 4 | $101 |
| Arcutis Biotherapeutics, Inc. | 4 | $94 |
| Mayne Pharma Commercial LLC | 4 | $90 |
| Botanix SB Inc | 4 | $72 |
| Incyte Corporation | 3 | $69 |
| Galderma Laboratories, L.p. | 4 | $65 |
| Almirall LLC | 2 | $49 |
| Merz North America, Inc. | 1 | $36 |
| Dermavant Sciences, Inc. | 1 | $25 |
| Dermira, Inc. | 1 | $23 |
| DUSA Pharmaceuticals, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Aclaris Therapeutics, Inc. | 1 | $18 |
| Journey Medical Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Sanofi | 1 | $17 |
| Amgen | 1 | $14 |
| Bristol Myers Squibb | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LEVULAN KERASTICK$4,902
- BLU-U$4,902
How this compares
$13,985 in reported general payments places this provider in the 85th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 30 | $167 |
| Triamcinolone Acetonide | 15 | $149 |
| Cephalexin | 21 | $64 |
| Doxycycline Hyclate | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Union City
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
- Tina BhutaniSan Francisco$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.